EBS

EBS Total Current Assets

$666.00MQuarterly · USD

Period ending:

EBS FY Current AssetsUSD
EBS FY Current Assets2001-12-31: $1.20B2002-12-31: $4.89M2004-12-31: $41.70M2005-12-31: $59.12M2006-12-31: $147.34M2007-12-31: $144.31M2008-12-31: $152.68M2009-12-31: $193.81M2010-12-31: $243.49M2011-12-31: $254.42M2012-12-31: $263.35M2013-12-31: $273.12M2014-12-31: $432.18M2015-12-31: $538.61M2016-12-31: $510.22M2017-12-31: $485.39M2018-12-31: $620.80M2019-12-31: $686.20M2020-12-31: $1.20B2021-12-31: $1.27B2022-12-31: $1.21B2023-12-31: $679.50M2024-12-31: $598.70M2025-12-31: $662.50M$1.27B$0.00
2001-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

EBS total current assets history

Assets expected to be converted to cash within one year. The available annual fiscal periods series contains 24 observations from Dec 31, 2001 to Dec 31, 2025.

Emergent Biosolutions Inc Total Current Assets — Annual fiscal periods (USD)
Period endingTotal Current Assets (USD)
662,500,000
598,700,000
679,500,000
1,210,400,000
1,269,900,000
1,195,900,000
686,200,000
620,800,000
485,389,000
510,218,000
538,612,000
432,175,000
273,115,000
263,347,000
254,418,000
243,493,000
193,814,000
152,679,000
144,310,000
147,337,000
59,116,000
41,695,000
4,891,000
1,195,900,000

Compare total current assets

All EBS financial metrics · EBS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.